Varian Medical Systems today announced it has received 510(k) clearance from the U.S. FDA to market the Nexus DR Digital X-Ray Imaging System
OREANDA-NEWS. Varian Medical Systems (NYSE: VAR) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Nexus DR, a high resolution imaging system for X-ray imaging using a digital X-ray detector. The Nexus DR is designed to replace conventional film techniques, or existing digital systems, in multipurpose or dedicated applications. The system is a single common imaging platform intended for general radiographic procedures (excluding fluoroscopy, angiography, and mammography).
The major components of the Nexus DR include an image detector, a computer, a high resolution monitor, and Varian's proprietary image processing software. Each system can be set up to process data from multiple detectors.
Nexus DR builds on Varian's current line of digital imaging software and workstation products, designed for installation into new or existing radiographic rooms or for use in mobile X-ray systems. It complies fully with the provisions of the European Medical Device Directive (MDD) and will soon be CE Marked.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiation. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy.